What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- DNA
Marco Bianchi mainly investigates HMGB1, Cell biology, Inflammation, Chromatin and Molecular biology.
His study with HMGB1 involves better knowledge in Immunology.
His work in Cell biology covers topics such as Receptor which are related to areas like Pharmacology.
The study incorporates disciplines such as Extracellular, Secretion and Cancer research in addition to Inflammation.
His Chromatin study incorporates themes from HMG-box, High-mobility group, Histone and Transcription factor.
His Molecular biology research includes elements of Necrosis, Base pair, DNA and Cell nucleus.
His most cited work include:
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (3266 citations)
- DAMPs, PAMPs and alarmins: all we need to know about danger (2133 citations)
- Bandgap opening in graphene induced by patterned hydrogen adsorption (1085 citations)
What are the main themes of his work throughout his whole career to date?
Marco Bianchi spends much of his time researching Prostatectomy, Prostate cancer, Internal medicine, Urology and HMGB1.
His study looks at the relationship between Prostatectomy and topics such as Surgery, which overlap with Nephrectomy.
Marco Bianchi focuses mostly in the field of Prostate cancer, narrowing it down to topics relating to Lymph node and, in certain cases, Radiology.
Internal medicine is closely attributed to Oncology in his research.
His HMGB1 research incorporates elements of RAGE, Cytokine and Cell biology.
Marco Bianchi works mostly in the field of Cell biology, limiting it down to topics relating to Chromatin and, in certain cases, Molecular biology.
He most often published in these fields:
- Prostatectomy (19.74%)
- Prostate cancer (19.74%)
- Internal medicine (18.59%)
What were the highlights of his more recent work (between 2017-2021)?
- Pembrolizumab (3.03%)
- Cystectomy (5.04%)
- Condensed matter physics (10.95%)
In recent papers he was focusing on the following fields of study:
Marco Bianchi mostly deals with Pembrolizumab, Cystectomy, Condensed matter physics, Internal medicine and Cell biology.
His work in Condensed matter physics tackles topics such as Photoemission spectroscopy which are related to areas like Angle-resolved photoemission spectroscopy, Molecular physics and Semiconductor.
Within one scientific family, Marco Bianchi focuses on topics pertaining to Oncology under Internal medicine, and may sometimes address concerns connected to Prostate cancer, Prostatectomy and Confidence interval.
His biological study spans a wide range of topics, including Inflammation, HMGB1 and Transcription, Gene.
Marco Bianchi combines subjects such as RAGE, Immune system and Monocyte with his study of Inflammation.
His HMGB1 study combines topics from a wide range of disciplines, such as High-mobility group and Platelet.
Between 2017 and 2021, his most popular works were:
- Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study (208 citations)
- Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis (90 citations)
- Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies (81 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- DNA
His scientific interests lie mostly in HMGB1, Cystectomy, Pembrolizumab, Epitaxy and Cell biology.
His HMGB1 research incorporates themes from Biophysics, Platelet and Cancer research.
His Cystectomy research includes themes of Neoadjuvant therapy, Carcinoma and Oncology.
His Epitaxy research incorporates elements of Crystallography, Electronic structure, Photoemission spectroscopy, Electron diffraction and Scanning tunneling microscope.
His Cell biology research is multidisciplinary, incorporating elements of Inflammation, Chromatin and Nuclear protein.
His Inflammation research is multidisciplinary, incorporating perspectives in Receptor and Monocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
